Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / *W EXP 02/10/202
-
Total 13F shares
-
3,297,126
-
Share change
-
0
-
Total reported value
-
$638,000
-
Price per share
-
$0.20
-
Number of holders
-
16
-
Value change
-
$0
Institutional Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q3 2022
As of 30 Sep 2022,
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,297,126 shares.
The largest 10 holders included
683 Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BOXER CAPITAL, LLC, FRANKLIN RESOURCES INC, Castle Creek Arbitrage, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., Rock Springs Capital Management LP, and Samsara BioCapital, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.